Hyaluronan synthase (HAS) (HAS)

The hyaluronic acid (HA) synthesis machinery in dermal fibroblasts is primarily composed of three membrane-bound enzymes: hyaluronan synthase 1, 2, and 3 (HAS1, HAS2, HAS3) [1, 2, 16]. These enzymes utilize cytoplasmic UDP-glucuronic acid and UDP-N-acetylglucosamine to polymerize HA chains, which are simultaneously translocated across the plasma membrane into the extracellular space [2, 4, 10]. In dermal fibroblasts, HAS2 is the predominant isoform and is responsible for the production of high-molecular-weight HA, which maintains skin hydration, elasticity, and structural integrity [2, 5, 16]. The activity of this machinery is tightly regulated by growth factors such as TGF-beta and is sensitive to environmental stressors like UV radiation, which often leads to decreased HA levels and subsequent skin aging [3, 15, 16]. Dysregulation of HA synthesis is a key factor in several diseases, including cancer, where overproduction of HA by HAS2 or HAS3 promotes tumor cell migration, invasion, and metastasis through interactions with receptors like CD44 and RHAMM [9, 11, 17]. In contrast, the loss of HA in the dermis is a hallmark of photoaging and impaired wound healing [16, 19]. Pharmacological modulation of this machinery includes the use of 4-methylumbelliferone (4-MU) to inhibit HA synthesis in oncology and fibrosis, while retinoids and bio-stimulators are used to enhance HA production for dermatological applications [9, 15, 17, 20]. Safety concerns include the potential for systemic HA depletion to cause developmental defects or pulmonary hypertension, as well as the pro-inflammatory nature of low-molecular-weight HA fragments [9, 11, 16].

Other names

Hyaluronic acid synthaseHA synthaseHyaluronate synthaseHyaluronan synthase 1 (HAS1)Hyaluronan synthase 2 (HAS2)Hyaluronan synthase 3 (HAS3)

Inhibition of hyaluronan synthesis by depletion of UDP-glucuronic acid precursors and downregulation of HAS mRNA expression; stimulation of synthesis via growth factor-mediated upregulation of HAS genes [9, 10, 15, 17].